Yes - a breakthrough therapy and / or new formulation. Whether or not in a new formulation is all comes down to long term medical costs.
Imagine an insurer covering medical costs for a patient due to serious heart problems over 20-30 years.
Imagine what a drug that largely eliminates cardiotoxic effects of anthracyclines will do in terms of reducing cumulative patient care costs. Massive cost saving for insurers (or payers as they are called in the US).
Ann: Breakthrough Zantrene Heart Protection Discovery, page-86
-
- There are more pages in this discussion • 281 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
